Latest Mergers And Acquisitions News

Generation Development Group (GDG) reported a striking 170% jump in underlying net profit after tax for FY25, driven by strong revenue growth and strategic acquisitions. The company’s expanding funds under management and new partnerships signal robust momentum ahead.

Generation Development Group Limited reported a remarkable 555% increase in net profit for the 2025 financial year, alongside a strategic acquisition that brings Lonsec fully under its control.

CurveBeam AI Limited posted a strong 85% increase in revenue to $12.1 million for FY25, alongside a reduced net loss of $16.8 million. Despite operational improvements and a recent $11.58 million capital raise, the company flags material uncertainty over its ability to continue as a going concern.

Medibank has reported strong full-year results for 2025, with underlying net profit rising 8.5% and record policyholder growth, underpinned by disciplined cost management and strategic health investments.

Medibank Private Limited reported steady revenue growth and stable profit for FY25, while navigating ongoing cybercrime-related expenses and regulatory scrutiny. The insurer also announced increased dividends and outlined strategic investments in health services and digital transformation.

Way2VAT Ltd reported a 43% revenue increase to AUD 2.49 million in H1 FY25, driven by new enterprise contracts including a major deal with JLL. Despite improved operating losses and successful fundraising, the company faces ongoing net losses and liquidity concerns.

Aquirian Limited reported a 12.6% revenue increase to $26.07 million for FY25 but posted a $3.41 million statutory loss amid ramp-up costs and impairments. The company is advancing its Energetics and Technology divisions, including the Wubin Emulsion Facility and Collar Keeper® System.

Qoria Limited reported a robust FY2025 with 25% growth in annual recurring revenue and a 684% jump in EBITDA, underscoring its expanding leadership in global K12 safety and wellbeing platforms.

ImpediMed Limited has posted a 23% increase in revenue for the 2025 financial year, yet its net loss widened by 17%, with no dividends declared. The company’s financials, audited by Ernst & Young, reveal a complex picture of growth paired with escalating costs.

Smartgroup Corporation Ltd reported a solid first half for 2025 with revenue up 7% and net profit rising 11%, powered by strong novated leasing growth amid shifting electric vehicle policies.

Trajan Holdings delivered solid FY2025 results with revenue up 7.4% to $166.5 million and improved profitability despite transient costs and a biotech syringe loss. The company refinanced debt and set an optimistic FY2026 guidance range.

Trajan Group Holdings has reported record FY25 revenue of $166.5 million, beating guidance and setting a solid foundation for FY26 with continued organic growth and improved profitability.